Jump to content

Industrializing Immuno-Oncology Therapeutic Discovery Platforms

PEGS Boston, Virtual
July 15, 2020

We present concrete use cases supporting large molecule and cellular therapeutics R&D, end-to-end. Our special focus is on in silico molecule assembly, on mono- to multispecific activity comparisons, developability assessments, and on the development and evaluation of CAR T cell lines. The platform shows unmatched flexibility in handling and exploring novel therapeutic modalities and supports increased efficiency and speed in their development, among other benefits.

Request Resource

By submitting my data, I give consent to the collection, processing and use of my personal data in accordance with the Genedata privacy policy